Streetbeat News

Products Services

APCX

AppTech Payments has entered a strategic partnership with InstaCash to launch a mobile-to-mobile payment system. The collaboration aims to provide a seamless and secure payment experience for users.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 11:35 am

BBIO

BridgeBio Pharma has presented updated six-month results from its Phase 2 Cohort 5 trial of Infigratinib in Achondroplasia. The drug showed a significant and robust increase in annual height velocity, with a mean change of +3.38 cm/year from baseline.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 11:35 am

PGEN

The FDA has granted Breakthrough Therapy Designation for Precigen's PRGN-2012 Adenoverse Immunotherapy for Recurrent Respiratory Papillomatosis, potentially accelerating the development and review process.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 11:32 am

CYTK

Cytokinetics has announced the start of the MAPLE-HCM Phase 3 clinical trial of Aficamten compared to Metoprolol in patients with symptomatic obstructive hypertrophic cardiomyopathy.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 11:32 am

MULN

Mullen Technologies announced the integration of its PERSONA AI camera/sensor and video monitoring system across its electric vehicle (EV) lineups. The advanced system aims to enhance safety and user experience.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 11:31 am

BTCUSD

ETHUSD

Tom Lehman, co-founder of Genius.com, has launched Ethscriptions, a protocol allowing Ethereum users to create NFTs and digital assets on the blockchain. The protocol is similar to Bitcoin's Ordinals protocol and has seen nearly 30,000 Ethscriptions created within the first 18 hours of going live.

Portfolio Pulse from Mehab Qureshi

June 20, 2023 | 11:30 am

CVAC

CureVac has initiated a Phase 1 clinical trial for its cancer vaccine candidate, CV8102, targeting surgically resected glioblastoma. The first patient has been dosed in the study.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 11:26 am

MIST

Milestone Pharmaceuticals announced the publication of results from its Phase 3 RAPID clinical trial of Etripamil nasal spray in patients with PSVT in The Lancet. The trial demonstrated the efficacy and safety of the drug.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 11:18 am

LASE

Laser Photonics has secured an order for its CleanTech laser cleaning system for facility maintenance. The system is designed to remove contaminants and improve efficiency.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 11:04 am